CEO LEADERSHIP SERIES
ASHTON TWEED'S CEO INTERVIEWS
March 17, 2016
PASSION FOR PATIENT CARE HELPS BUILD BUSINESS As the CEO of Orthotic Holdings Inc. (OHI), Ivan R. Sabel draws on his experience as both a practitioner […]
January 29, 2016
MAKING CONNECTIONS AND SEIZING OPPORTUNITIES Kathleen P. DeLawrence, Chief Operating Officer of Ability Prosthetics & Orthotics, Inc., has an impressive breadth of experience in the pharmaceutical, […]
December 9, 2015
AFTER DECADES AT MERCK, A NEW ENTREPRENEURIAL BEGINNING After 26 years at Merck & Co. Inc., Graham G. Lumsden was evaluating his career options. He decided […]
October 28, 2015
FROM BIG PHARMA LAYOFF TO LAUNCHING A CRO When Renold J. Capocasale learned that he was being laid off by Johnson & Johnson, where he had […]
September 21, 2015
FROM SEED FUNDING TO FDA APPROVAL IN 20 MONTHS! The biopharmaceutical industry was abuzz earlier this month with the long-awaited launch of Sandoz’ Zarxio™ (filgrastim-sndz), the […]
August 12, 2015
TRANSITIONING FROM SCIENTIST TO CEO By the time he co-founded PDS Biotechnology Corp., a clinical-stage biotech company in North Brunswick, N.J., Dr. Frank K. Bedu-Addo had […]
June 28, 2015
HOW TO REINVENT YOURSELF IN TURBULENT TIMES David Owens is an expert on reinvention and the unconventional path to the C-suite. In 2009, after 30 years in […]
May 15, 2015
THE IMPORTANCE OF BUILDING A STRONG BOARD OF DIRECTORS The composition of a company’s board of directors ultimately can make or break a business. Warren Cooper, […]
September 4, 2014
PRIVATE VS. PUBLIC COMPANY LEADERSHIP “To be successful as a chief executive officer, you have to know how to run an enterprise. You have to be […]
April 17, 2014
MAKING A SMOOTH TRANSITION FROM A LARGE MEDICAL DEVICE FIRM TO A SMALL BIOPHARMACEUTICAL COMPANY Last year, David Johnson made a big change in his career […]
September 1, 2012
USING VIRTUAL BIOTECHS TO MOVE DRUGS INTO DEVELOPMENT MORE EFFICIENTLY This year, Bridgewater, NJ-based Drais Pharmaceuticals, Inc., has launched a new business model. According to Drais […]
June 1, 2012
SUCCESS STRATEGIES FOR NEW DRUG DEVELOPMENT TODAY Originally published in Ashton Tweed Connection, Summer 2012 As the former President and CEO of Prism Pharmaceuticals, Dr. Warren […]
April 1, 2012
SUCCESSFULLY RIDING THE WAVE OF CHANGE IN PHARMA TODAY Originally published in Ashton Tweed Connection, April 2012 In 2005, Nick Spring cofounded Topaz Pharmaceuticals — a […]
February 1, 2012
THE RISKS AND REWARDS OF ENTREPRENEURSHIP Originally published in Ashton Tweed Connection, February 2012 What are the risks and rewards of entrepreneurship? That’s what we asked […]
ARE YOU A CEO INTERESTED IN JOINING OUR LEADERSHIP SERIES?
CONTACT US TO DISCUSS AN INTERVIEW:
Jordan Warshafsky
Partner, Ashton Tweed Ltd.
Email: JWarshafsky@ashtontweed.com
Phone: 610.725.0290 x441
Ashton Tweed, Ltd.
314 S. Henderson Rd.
Suite G370
King of Prussia, PA 19406